INPLASY202440101

Comparative efficacy and safety of different recommended doses of telitacicept in patients with systemic lupus erythematosus in China: A systematic review and meta-analysis

Keywords: B-cell activating factor, systemic lupus erythematosus, efficacy, safety.

Download PDF - 202440101

Download 4th Version - This version was published on 23 July 2024 and is not the current version.

Download 3rd Version - This version was published on 12 July 2024 and is not the current version.

Download 2nd Version - This version was published on 14 June 2024 and is not the current version.

Download 1st Version - This version was published on 25 April 2024 and is not the current version.

Review Status: Ongoing